(Press-News.org) In a major advance for schizophrenia research, an international team of scientists, led by Jonathan Sebat, PhD, assistant professor of psychiatry and cellular and molecular medicine at the University of California, San Diego School of Medicine, has identified a gene mutation strongly linked to the brain disorder – and a signaling pathway that may be treatable with existing compounds.
The work poses significant and immediate implications for neurobiology and the treatment of schizophrenia because the gene identified by the researchers is an especially attractive target for drug development.
"In some ways, this is the kind of gene that the pharmaceutical industry has been waiting for," said Sebat, who is also chief of the Beyster Center for Molecular Genomics of Neuropsychiatric Diseases and a member of the Institute for Genomic Medicine, both at UC San Diego. "Its activity can be modulated by synthetic peptides; and some have already been created."
The findings are published in the Feb. 3, 2011 online issue of the journal Nature.
Schizophrenia is a chronic, severe and disabling brain disorder, with symptoms that include hallucinations, delusions and thought disorders. It is believed to be caused by environmental and genetic factors, most notably the latter: the illness occurs in 1 percent of the general population, or 10 percent of people who have a first-degree relative with the disorder, such as a parent or sibling.
In previous work, Sebat and collaborator Mary-Claire King, a professor of medical genetics at the University of Washington, discovered that rare mutations at many locations in the human genome resulted in significantly higher risk of schizophrenia. These mutations consisted of copy number variants or CNVs – a type of genetic variation in which the number of copies of a gene differs between individuals. The findings were the first conclusive evidence that rare mutations can cause schizophrenia, but they did not identify the specific genes involved.
The latest study goes much further. Researchers scanned for CNVs in the genomes of 8,290 individuals with diagnosed cases of schizophrenia and 7,431 healthy controls. "We found very strong links to multiple sites in the genome," said Sebat. "Some had been picked up before in earlier studies, but we uncovered a very important new finding: duplications at the tip of chromosome 7q were detected in individuals with schizophrenia at a rate14 times higher than in healthy individuals. These CNVs impact a gene that is important for brain development – the neuropeptide receptor VIPR2."
Formally known as the Vasoactive Intestinal Peptide Receptor 2, VIPR2 is expressed in the nervous system, including in the brain, blood vessels and gastrointestinal tract. Previous studies have shown that VIPR2 helps to regulate the formation and activity of neurons in the brain. In mice, VIPR2 also has been found to play important roles in behavioral processes, including learning and timing of daily activity.
Sebat and colleagues measured expression of the VIPR2 gene in blood cells from the patients, and they found that individuals with mutations had greater expression of VIPR2 and greater activity of the receptor. "We concluded that the effect of the causal mutations is to raise the volume on the VIP signaling pathway," said Sebat.
"This discovery might be the best target yet to come out of genetic studies of mental illness." said Sebat. "This is what genomic medicine is all about, finding the relevant genes and using this genetic information to come up with a possible strategy for treatment."
Sebat said the next step will be to test whether compounds like these have beneficial effects in mice and in cultured human cells that carry the VIPR2 gene mutation.
INFORMATION:
Co-authors of the paper are Vladimir Vacic, Stanley Center for Cognitive Genomics, Cold Spring Harbor Laboratory and the Department of Computer Science, Columbia University; Shane McCarthy, Stanley Center for Cognitive Genomics, Cold Spring Harbor Laboratory; Dheeraj Malhotra, Beyster Center for Genomics of Psychiatric Diseases, UCSD Department of Psychiatry and Stanley Center for Cognitive Genomics, Cold Spring Harbor Laboratory; Fiona Murray, UCSD departments of Medicine and Pharmacology; Hsun-Hua Chou, Beyster Center for Genomics of Psychiatric Diseases and UCSD Department of Psychiatry; Aine Peoples, Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine and Department of Psychiatry, Trinity College Dublin, Ireland; Vladimir Makarov and Seungtai Yoon, Seaver Autism Center and Department of Psychiatry, Mount Sinai School of Medicine, New York; Abhishek Bhandari, Beyster Center for Genomics of Psychiatric Diseases, UCSD Department of Psychiatry, Stanley Center for Cognitive Genomics, Cold Spring Harbor Laboratory; Roser Corominas and Lilia M. Iakoucheva, UCSD Department of Psychiatry; Olga Krastoshevsky, Verena Krause and Deborah L. Levy, McLean Hospital, Belmont, MA; Verónica Larach-Walters, Universidad Andrés Bello, Santiago, Chile; David K. Welsh, UCSD Department of Psychiatry, UCSD Center for Chronobiology, Veterans Affairs San Diego Healthcare System; David Craig, Neurogenomics Division, Translational Genomics Research Institute; John R. Kelsoe, UCSD Department of Psychiatry, UCSD Institute for Genomic Medicine, Veterans Affairs San Diego Healthcare System; Elliot S. Gershon, Department of Psychiatry and Behavioral Neuroscience, The University of Chicago; Suzanne M. Leal, Department of Molecular and Human Genetics, Baylor College of Medicine; Marie Dell Aquila, UCSD Division of Medical Genetics, UCSD Department of Medicine; Derek W. Morris, Michael Gill and Aiden Corvin, Neuropsychiatric Genetics Research Group, Institute of Molecular Medicine and Department of Psychiatry, Trinity College Dublin, Ireland; Paul A. Insel, UCSD Department of Pharmacology, Veterans Affairs San Diego Healthcare System; Jon McClellan, Department of Psychiatry, University of Washington; Mary-Claire King, departments of Genome Sciences and Medicine, University of Washington; Maria Karayiorgou, Department of Psychiatry, Columbia University; and Lynn E. DeLisi, Department of Psychiatry, Boston VA Healthcare System and Harvard Medical School.
Funding for this research came, in part, from the Stanley Medical Research Foundation, the Beyster Family Foundation, the National Alliance for Research on Schizophrenia and Depression and the National Institutes of Health.
Schizophrenia gene mutation found; target for new drugs
2011-02-03
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Cell reprogramming leaves a 'footprint' behind
2011-02-03
LA JOLLA, CA—Reprogramming adult cells to recapture their youthful "can-do-it-all" attitude appears to leave an indelible mark, found researchers at the Salk Institute for Biological Studies. When the team, led by Joseph Ecker, PhD., a professor in the Genomic Analysis Laboratory, scoured the epigenomes of so-called induced pluripotent stem cells base by base, they found a consistent pattern of reprogramming errors.
What's more, these incompletely or inadequately reprogrammed hotspots are maintained when iPS cells are differentiated into a more specialized cell type, ...
Why folic acid may prevent a first heart attack, but not a second
2011-02-03
A perplexing medical paradox now has an explanation according to research undertaken at Barts and The London School of Medicine and Dentistry and published in the current issue of the Public Library of Science. The paradox is that taking folic acid, a B vitamin, lowers homocysteine in the blood which, epidemiological evidence indicates, should lower the risk of heart attack, but clinical trials of folic acid have not shown the expected benefit.
The explanation is surprisingly simple; lowering homocysteine prevents platelets sticking, which stops blood clots…something ...
Could the humble sea cucumber save our seas?
2011-02-03
It may look like an over-grown slug, but scientists at Newcastle University believe the sea cucumber could play a vital role in the fight to save our seas - and become an unusual addition to British gourmet food.
Not only is this salty Asian delicacy a rich source of nutrients, it is also an important part of the marine ecosystem. Much like worms working soil in a garden, sea cucumbers are responsible for cleaning up the sea bed - moving, consuming and mixing marine sediments.
Used widely in Chinese medicine and cuisine, sea cucumbers are also a rich source of glucosamine ...
Giant virus, tiny protein crystals show X-ray laser's power and potential
2011-02-03
Menlo Park, Calif. — Two studies published in the February 3 issue of Nature demonstrate how the unique capabilities of the world's first hard X-ray free-electron laser—the Linac Coherent Light Source, located at the Department of Energy's SLAC National Accelerator Laboratory—could revolutionize the study of life.
In one study, an international research team used the LCLS to demonstrate a shortcut for determining the 3-D structures of proteins. The laser's brilliant pulses of X-ray light pulled structural data from tiny protein nanocrystals, avoiding the need to use ...
Vegans' elevated heart risk requires omega-3s and B12
2011-02-03
People who follow a vegan lifestyle — strict vegetarians who try to eat no meat or animal products of any kind — may increase their risk of developing blood clots and atherosclerosis or "hardening of the arteries," which are conditions that can lead to heart attacks and stroke. That's the conclusion of a review of dozens of articles published on the biochemistry of vegetarianism during the past 30 years. The article appears in ACS' bi-weekly Journal of Agricultural and Food Chemistry.
Duo Li notes in the review that meat eaters are known for having a significantly higher ...
New gift from Mother Nature’s medicine chest may help prevent and treat bone diseases
2011-02-03
One of Mother Nature's latest gifts to medical science is stirring excitement with the discovery that the substance — obtained from a coral-reef inhabiting cyanobacterium — appears to be an ideal blueprint for developing new drugs for serious fractures, osteoporosis, and other bone diseases. That's the conclusion of a study on the substance, Largazole, in the journal ACS Medicinal Chemistry Letters.
By some estimates, more than half of today's medications are in Largazole's family, the "natural products." They come from trees, snails, scorpion venom, soil bacteria, other ...
'Red mud' disaster's main threat to crops is not toxic metals
2011-02-03
As farmers in Hungary ponder spring planting on hundreds of acres of farmland affected by last October's red mud disaster, scientists are reporting that high alkalinity is the main threat to a bountiful harvest, not toxic metals. In a study in the ACS journal Environmental Science & Technology, they also describe an inexpensive decontamination strategy using the mineral gypsum, an ingredient in plaster.
Erik Smolders and colleagues note that a dam burst at a factory processing aluminum ore, flooding the surrounding land with more than 700,000 cubic yards of a byproduct ...
Shoo fly: Catnip oil repels bloodsucking flies
2011-02-03
Catnip, the plant that attracts domestic cats like an irresistible force, has proven 99 percent effective in repelling the blood-sucking flies that attack horses and cows, causing $2 billion in annual loses to the cattle industry. That's the word from a report published in ACS' biweekly Journal of Agricultural and Food Chemistry.
Junwei Zhu and colleagues note that stable flies not only inflict painful bites, but also transmit multiple diseases. Cattle harried by these bloodsuckers may produce less meat and milk, have trouble reproducing, and develop diseases that can ...
Secrets of plant warfare underpin quest for safer, more secure global food supply
2011-02-03
Like espionage agents probing an enemy's fortifications, scientists are snooping out the innermost secrets of the amazing defense mechanisms that plants use to protect themselves from diseases. The effort — intended to discover ways of bolstering those natural defenses and enhance the safety and security of the global food supply — is the topic of an article in the current edition of Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.
C&EN Associate Editor Sarah Everts notes that plants use a battery of cunning mechanisms to protect themselves from disease. ...
MicroRNA cocktail helps turn skin cells into stem cells
2011-02-03
LA JOLLA, Calif., February 1, 2011 – Stem cells are ideal tools to understand disease and develop new treatments; however, they can be difficult to obtain in necessary quantities. In particular, generating induced pluripotent stem (iPS) cells can be an arduous task because reprogramming differentiated adult skin cells into iPS cells requires many steps and the efficiency is very low – researchers might end up with only a few iPS cells even if they started with a million skin cells. A team at Sanford-Burnham Medical Research Institute (Sanford-Burnham) set out to improve ...